CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 9, 2021
December 9, 2021
79b344db-7419-48ec-a38a-6715baf127b4
Related Documents
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Guidance DocumentJuly 27, 2022Center for Drug Evaluation and Research
Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA
Guidance DocumentOctober 13, 2022Center for Drug Evaluation and Research
Advanced Manufacturing Technologies Designation Program
Guidance DocumentDecember 31, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox